
VSTM
Healthcare · Biotechnology · $1.03B market cap
$8.18-0.26 (-3.1%)Nov 13, 4:13 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +4.7% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.44 | -0.74 | -68.2% |
| Aug 6, 2026 | After the close | -0.46 | -0.35 | +23.9% |
| May 7, 2026 | After the close | -0.47 | -0.43 | +8.5% |
| Mar 5, 2026 | Time not confirmed | -0.50 | -0.46 | +7.5% |
| Nov 4, 2025 | Before the open | -0.61 | -0.54 | +11.5% |
| Aug 7, 2025 | After the close | -0.59 | -0.39 | +33.9% |
| May 13, 2025 | After the close | -0.77 | -0.79 | -2.6% |
| Mar 12, 2025 | Before the open | -0.74 | -0.60 | +18.6% |
| Nov 6, 2024 | After the close | -0.82 | -0.88 | -7.3% |
| Aug 8, 2024 | After the close | -1.06 | -0.61 | +42.5% |
| May 9, 2024 | After the close | -0.87 | -0.98 | -12.6% |
| Mar 14, 2024 | After the close | -0.62 | -1.02 | -64.5% |
| Nov 8, 2023 | After the close | -0.79 | -0.71 |
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway…
| +10.1% |
| Aug 8, 2023 | After the close | -1.02 | -1.15 | -12.7% |
| May 9, 2023 | After the close | -0.98 | -1.14 | -16.3% |
| Mar 14, 2023 | After the close | -0.10 | -0.08 | +20.0% |
| Nov 3, 2022 | After the close | -1.47 | -1.08 | +26.5% |
| Aug 8, 2022 | Before the open | -1.32 | -1.44 | -9.1% |
| May 9, 2022 | After the close | -1.02 | -1.08 | -5.9% |
| Mar 28, 2022 | Before the open | -0.09 | -0.09 | 0.0% |
| Nov 4, 2021 | After the close | -0.84 | -1.56 | -85.7% |
| Aug 2, 2021 | After the close | -1.00 | -1.20 | -20.0% |
| May 11, 2021 | After the close | -1.08 | -1.08 | 0.0% |
| Mar 18, 2021 | After the close | -0.08 | -0.12 | -50.0% |
| Nov 9, 2020 | After the close | 0.52 | 0.96 | +84.6% |
| Aug 10, 2020 | Before the open | -1.76 | -1.68 | +4.5% |
| May 7, 2020 | After the close | -2.58 | -4.20 | -62.8% |
| Mar 11, 2020 | After the close | -0.45 | -0.51 | -13.3% |
| Oct 29, 2019 | After the close | -4.92 | -4.20 | +14.6% |
| Aug 1, 2019 | After the close | -5.84 | -5.76 | +1.4% |
| May 9, 2019 | After the close | -5.64 | -6.24 | -10.6% |
| Mar 12, 2019 | After the close | -0.53 | -0.49 | +7.5% |
| Nov 7, 2018 | After the close | -4.68 | -5.97 | -27.6% |
| Aug 8, 2018 | After the close | -4.30 | -5.56 | -29.3% |
| May 3, 2018 | After the close | -0.39 | -0.41 | -5.1% |
| Mar 13, 2018 | Before the open | -5.10 | -5.16 | -1.2% |